You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

15-235

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plaque Psoriasis Trial in Worldwide (JNJ-77242113, Placebo)

Active, not recruiting
  • Plaque Psoriasis
  • Beverly Hills, California
  • +33 more
Jan 17, 2023

Metastatic NSCLC (NSCLC) Trial in Worldwide (Durvalumab, Danvatirsen, Oleclumab)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer (NSCLC)
  • Iowa City, Iowa
  • +45 more
Jan 13, 2023

COVID-19 Trial in Salt Lake City (EDP-235, Midazolam, Rosuvastatin)

Recruiting
  • COVID-19
  • Salt Lake City, Utah
    ICON, plc.
Oct 21, 2022

Non Small Cell Lung Carcinoma NSCLC Trial in Worldwide (Durvalumab (MEDI4736), Paclitaxel + carboplatin, Gemcitabine +

Active, not recruiting
  • Non Small Cell Lung Carcinoma NSCLC
  • Durvalumab (MEDI4736)
  • +5 more
  • Anaheim, California
  • +92 more
Jan 31, 2023

Systemic Lupus Erythematosus Trial in Worldwide (Lupuzor)

Terminated
Has Results
  • Systemic Lupus Erythematosus
  • Birmingham, Alabama
  • +84 more
Dec 5, 2022

Body Composition and White Adipose Tissue Inflammation

Active, not recruiting
  • Breast Cancer
  • +3 more
  • DEXA Scan
  • Godin Leisure Time Exercise Questionnaire (GLTEQ)
  • Milford, Massachusetts
  • +7 more
Dec 19, 2022

Asthma Trial in Worldwide (Benralizumab)

Completed
Has Results
  • Asthma
  • Benralizumab
  • Flagstaff, Arizona
  • +143 more
Jun 22, 2022

COVID-19 Trial in United States (EDP-235, Placebo)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +20 more
Dec 6, 2022

Multiple Sclerosis Trial in Hamburg (levidex, Control, treatment as usual (TAU))

Not yet recruiting
  • Multiple Sclerosis
  • levidex
  • +2 more
  • Hamburg, Germany
    GAIA AG
Oct 19, 2023

Seasonal Allergic Rhinitis Trial (montelukast sodium, Comparator: loratadine, Comparator: Placebo)

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • montelukast sodium
  • +2 more
  • (no location specified)
Feb 1, 2022

COVID-19 Trial in Lenexa (EDP-235, Itraconazole, Carbamazepine)

Recruiting
  • COVID-19
  • Lenexa, Kansas
    ICON, plc.
Oct 21, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Monalizumab, Cetuximab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +126 more
Oct 21, 2022

COPD (COPD), Chronic Bronchitis Trial in Worldwide (MEDI3506, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Bronchitis
  • MEDI3506
  • Placebo
  • Sheffield, Alabama
  • +125 more
Jul 28, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Alzheimer, Dementia, Brain Diseases Trial in Worldwide (Donanemab, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • +8 more
  • Brussels, Bruxelles-Capitale, Région De, Belgium
  • +147 more
Aug 18, 2022

Tobacco Use Disorder Trial in Baltimore, Burlington (Very low nicotine content cigarettes)

Completed
Has Results
  • Tobacco Use Disorder
  • Very low nicotine content cigarettes
  • Baltimore, Maryland
  • +1 more
Nov 15, 2022

Tobacco Use Disorder Trial in Baltimore, Burlington (Very low nicotine content cigarettes)

Completed
Has Results
  • Tobacco Use Disorder
  • Very low nicotine content cigarettes
  • Baltimore, Maryland
  • +1 more
Nov 15, 2022

Small Cell Lung Carcinoma Extensive Disease Trial in Worldwide (Durvalumab, Tremelimumab, Carboplatin)

Active, not recruiting
Has Results
  • Small Cell Lung Carcinoma Extensive Disease
  • Birmingham, Alabama
  • +205 more
Mar 11, 2022

SARS CoV 2 Infection Trial in Lenexa (EDP-235, Placebo)

Recruiting
  • SARS CoV 2 Infection
  • Lenexa, Kansas
    Pharmaceutical Research Associates, Inc.,
Feb 22, 2022

Rosacea Trial in Worldwide (CLS001 (Omiganan), Vehicle)

Completed
Has Results
  • Rosacea
  • Fremont, California
  • +40 more
Jul 31, 2022

Sarcopenia Trial in New Taipei City (HINEX Jelly ( jelly high protein supplement))

Active, not recruiting
  • Sarcopenia
  • HINEX Jelly ( jelly high protein supplement)
  • New Taipei City, Zhonghe Dist., Taiwan
    Taipei Medical University
Jun 28, 2023

Bronchiolectasis Trial in Lahore (PEP (Positive Expiratory Pressure), IS (Incentive spirometry))

Completed
  • Bronchiolectasis
  • PEP (Positive Expiratory Pressure)
  • IS (Incentive spirometry)
  • Lahore, Punjab, Pakistan
    Mayo Hospital Lahore
Jan 31, 2023

Psoriatic Arthritis Trial in Worldwide (Apremilast 20mg, Apremilast 30mg, Placebo)

Completed
Has Results
  • Psoriatic Arthritis
  • Apremilast 20mg
  • +2 more
  • Phoenix, Arizona
  • +117 more
May 26, 2022

Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,

Recruiting
  • Epstein-Barr Virus Positive
  • +10 more
  • Atlanta, Georgia
  • +2 more
Dec 10, 2022

Unresectable Hepatocellular Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Chicago, Illinois
  • +6 more
Jan 18, 2023